Hiroshi Katsuki Selected Research

SK&F 10047

11/2002

Antagonism of NMDA receptors by sigma receptor ligands attenuates chemical ischemia-induced neuronal death in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Katsuki Research Topics

Disease

22	Cerebral Hemorrhage 01/2022 - 04/2006
12	Hematoma 01/2022 - 07/2007
9	Parkinson Disease (Parkinson's Disease) 12/2021 - 01/2003
8	Narcolepsy 01/2018 - 02/2004
7	Ganglion Cysts (Ganglion) 08/2009 - 06/2002
6	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 08/2003
5	Inflammation (Inflammations) 01/2022 - 02/2009
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 12/2003
5	Mental Disorders (Mental Disorder) 12/2020 - 01/2016
5	Neuroblastoma 01/2016 - 03/2005
5	Brain Injuries (Brain Injury) 07/2013 - 07/2004
5	Neoplasms (Cancer) 02/2011 - 01/2008
4	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2021 - 12/2018
4	Sleep Deprivation 01/2018 - 07/2013
4	Sleep Wake Disorders 01/2018 - 02/2004
4	Hemorrhage 01/2017 - 03/2008
4	Ischemia 11/2004 - 06/2002
3	Nervous System Diseases (Neurological Disorders) 12/2021 - 01/2010
3	Acute Promyelocytic Leukemia 01/2012 - 07/2009
3	Necrosis 10/2011 - 09/2003
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2021 - 01/2012
2	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 01/2021 - 01/2021
2	Disorders of Excessive Somnolence (Hypersomnia) 01/2017 - 12/2010
2	Glioma (Gliomas) 01/2016 - 01/2008
2	Hypoxia (Hypoxemia) 06/2013 - 02/2009
2	Brain Edema (Cerebral Edema) 10/2011 - 09/2011
2	Edema (Dropsy) 10/2011 - 01/2011
2	Wounds and Injuries (Trauma) 09/2009 - 04/2006
2	Hemolysis 09/2004 - 11/2003
1	Encephalitis (Encephalitis, Rasmussen) 01/2022
1	Hemorrhagic Stroke 12/2021
1	Central Nervous System Diseases (CNS Diseases) 12/2021
1	Stroke (Strokes) 09/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Ototoxicity 01/2021
1	Ureteral Obstruction 10/2020
1	Fibrosis (Cirrhosis) 10/2020

Drug/Important Bio-Agent (IBA)

11	Thrombin FDA Link 08/2020 - 04/2006
10	OrexinsIBA 01/2018 - 02/2004
7	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 12/2021 - 01/2011
7	Therapeutic UsesIBA 12/2021 - 09/2011
7	tamibaroteneIBA 10/2020 - 07/2009
6	Pharmaceutical PreparationsIBA 12/2021 - 01/2012
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2009
6	Collagenases (Collagenase)FDA Link 01/2017 - 07/2007
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 12/2003
5	Glutamic Acid (Glutamate)FDA Link 02/2007 - 07/2004
4	LigandsIBA 01/2022 - 11/2002
4	Glycoproteins (Glycoprotein)IBA 01/2021 - 10/2009
4	CytokinesIBA 08/2020 - 02/2009
4	Neuroprotective AgentsIBA 12/2018 - 01/2003
4	RetinoidsIBA 08/2014 - 01/2011
4	Retinaldehyde (Retinal)IBA 03/2006 - 01/2003
3	Nicotine FDA Link 09/2021 - 09/2011
3	Cysteine (L-Cysteine)FDA Link 01/2021 - 10/2005
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2020 - 10/2008
3	Adenosine Triphosphatases (ATPase)IBA 09/2019 - 01/2016
3	NeuropeptidesIBA 01/2017 - 01/2010
3	Messenger RNA (mRNA)IBA 01/2016 - 02/2009
3	Mitogen-Activated Protein KinasesIBA 10/2015 - 07/2007
3	Nitric Oxide Synthase (NO Synthase)IBA 12/2014 - 01/2004
3	Oxygen (Dioxygen)IBA 01/2009 - 10/2004
3	Dopamine (Intropin)FDA LinkGeneric 03/2008 - 10/2005
3	Donepezil (Aricept)FDA LinkGeneric 08/2007 - 08/2003
3	N-Methylaspartate (NMDA)IBA 03/2006 - 01/2003
3	Glucose (Dextrose)FDA LinkGeneric 11/2004 - 09/2004
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2004 - 11/2002
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2022 - 12/2021
2	Amodiaquine (Camoquin)FDA Link 01/2022 - 01/2019
2	GlucocorticoidsIBA 12/2020 - 01/2010
2	EnzymesIBA 08/2020 - 11/2004
2	Leukotriene B4IBA 08/2020 - 01/2017
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 10/2015 - 01/2004
2	ropinirole (Requip)FDA LinkGeneric 01/2012 - 12/2010
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2012 - 12/2010
2	Glycyrrhizic Acid (Glycyrrhizin)IBA 10/2011 - 01/2010
2	Blood Coagulation Factors (Coagulation Factor)IBA 08/2010 - 01/2009
2	Serine Proteases (Serine Protease)IBA 08/2010 - 04/2006
2	LipopolysaccharidesIBA 01/2010 - 07/2009
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 08/2007 - 09/2006
2	Glutathione (Reduced Glutathione)IBA 02/2007 - 10/2005
2	quinone (benzoquinone)IBA 10/2005 - 03/2005
1	CC ChemokinesIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022
1	Liver X ReceptorsIBA 12/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2021
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 09/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	IgA receptor (protein B)IBA 01/2021
1	metabotropic glutamate receptor type 1IBA 01/2021
1	Ataxin-1IBA 01/2021
1	CholesterolIBA 01/2021
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 08/2020
1	Arachidonic Acid (Vitamin F)IBA 08/2020

Therapy/Procedure

5	Therapeutics 12/2021 - 07/2009
3	Oral Administration 02/2020 - 07/2009
3	Drug Therapy (Chemotherapy) 09/2014 - 01/2008
2	Intravitreal Injections 08/2003 - 01/2003